Andre Terzic, M.D., Ph.D., is the inaugural Michael S. and Mary Sue Shannon Director, Mayo Clinic Center for Regenerative Medicine. Recognized with the distinction of Marriott Family Professor in Cardiovascular Diseases and Marriott Family Director of Comprehensive Cardiac Regenerative Medicine, he is Professor of Medicine and Pharmacology; Chair, Discovery-Translation Advisory Board; and Director, National Institutes of Health “Cardiovasology” Program. He serves on the Board of Directors, Mayo Clinic Collaborative Services.
Nationally, Dr. Terzic was elected President, American Society for Clinical Pharmacology & Therapeutics; Chair, Functional Genomics & Translational Biology Council, American Heart Association; and Chair, Scientific Advisory Board, International Society for Cardiovascular Translational Research. He serves on the National Institute of Health Protocol Review Committee, NHLBI Cardiovascular Cell Therapy Research Network, and lead coordinator, Leducq Foundation Transatlantic Network of Excellence Program.
Elected to the American Society of Clinical Investigation and Fellow of the American Heart Association, Dr. Terzic pioneered regenerative medicine at Mayo Clinic, authoring over 500 publications cited to date over 13,000 times. He is a member of Steering Committees and Data and Safety Monitoring Boards, and has been nominated to the Food and Drug Administration Advisory Committee for Pharmaceutical Science and Clinical Pharmacology. He is on a number of editorial boards.
Dr. Terzic is recognized with numerous national and international distinctions. He is the recipient of the American Heart Association Basic Research Prize “for pioneering applications of emerging technologies to advance the diagnosis and treatment of cardiovascular disorders”. He has been awarded the Medal of Merit, International Society for Heart Research; Leon I. Goldberg Award, American Society for Clinical Pharmacology and Therapeutics: Klaus Unna Award, University of Illinois; Established Investigator Award, American Heart Association; and at Mayo Clinic with the Excellence in Teaching Award, Outstanding Cardiovascular Research Mentor Award, Landmark Contribution to the Literature Award and Outstanding Investigator Award. He is the recipient of the Martin E. Rehfuss Medal in Medicine, Thomas Jefferson University; Henry W. Elliott Distinguished Service Award, American Society for Clinical Pharmacology and Therapeutics; PhRMA Foundation Excellence in Clinical Pharmacology Award; Ueda Memorial Award, Japanese Society of Electrocardiology; Benedict Lucchesi Distinguished Award in Cardiac Pharmacology, American Society for Pharmacology and Experimental Therapeutics; and the Functional Genomics and Translational Biology Mentoring Award, conferred by the American Heart Association.
Dr. Terzic trained at University of Paris, Belgrade and Illinois followed by fellowships at the French National Institutes of Health, Thomas Jefferson University and Mayo Clinic.